These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11535638)

  • 1. Killing of dendritic cells: a life cut short or a purposeful death?
    Ronchese F; Hermans IF
    J Exp Med; 2001 Sep; 194(5):F23-6. PubMed ID: 11535638
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficient generation of survivin-specific cytotoxic T lymphocytes from healthy persons in vitro: quantitative and qualitative effects of CD4+ T cells.
    Kim EK; Cho HI; Yoon SH; Park MJ; Sohn HJ; Kim HJ; Oh ST; Kim TG
    Vaccine; 2008 Jul; 26(32):3987-97. PubMed ID: 18584926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human immunodeficiency virus type 1 replication in primary CD4(+) T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytes.
    Severino ME; Sipsas NV; Nguyen PT; Kalams SA; Walker BD; Johnson RP; Yang OO
    J Virol; 2000 Jul; 74(14):6695-9. PubMed ID: 10864688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CD4 T cell help for CD8 CTL activation.
    Zhang S; Zhang H; Zhao J
    Biochem Biophys Res Commun; 2009 Jul; 384(4):405-8. PubMed ID: 19410556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of H-Y-reactive T lymphocytes in primary mixed lymphocyte reaction in DA rats.
    Sugiura W; Miyamoto M; Kimura H; Imada M; Tsujimura K; Honda M; Yamashita A
    Transplant Proc; 1995 Apr; 27(2):1593-5. PubMed ID: 7725418
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential susceptibility of leukocyte subsets to cytotoxic T cell killing: implications for HIV immunopathogenesis.
    Liu J; Roederer M
    Cytometry A; 2007 Feb; 71(2):94-104. PubMed ID: 17200952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mathematical model for the immunosenescence.
    Luciani F; Turchetti G; Franceschi C; Valensin S
    Riv Biol; 2001; 94(2):305-18. PubMed ID: 11702654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24.
    Rew SB; Peggs K; Sanjuan I; Pizzey AR; Koishihara Y; Kawai S; Kosaka M; Ozaki S; Chain B; Yong KL
    Clin Cancer Res; 2005 May; 11(9):3377-84. PubMed ID: 15867238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the in vivo and in vitro response of human T cells to porcine islets.
    Olack B; Poindexter N; Swanson C; Steward N; Howard T; Mohanakumar T
    Transplant Proc; 1999; 31(1-2):648-9. PubMed ID: 10083279
    [No Abstract]   [Full Text] [Related]  

  • 11. Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity.
    Smith CM; Wilson NS; Waithman J; Villadangos JA; Carbone FR; Heath WR; Belz GT
    Nat Immunol; 2004 Nov; 5(11):1143-8. PubMed ID: 15475958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell competition for the antigen-presenting cell as a model for immunodominance in the cytotoxic T lymphocyte response against minor histocompatibility antigens.
    Grufman P; Wolpert EZ; Sandberg JK; Kärre K
    Eur J Immunol; 1999 Jul; 29(7):2197-204. PubMed ID: 10427982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naive CD8(+) but not CD4(+) T cells induce maturation of dendritic cells.
    Schüler T; Blankenstein T
    J Mol Med (Berl); 2002 Aug; 80(8):533-41. PubMed ID: 12185454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells stimulate the expansion of PML-RAR alpha specific cytotoxic T-lymphocytes: its applicability for antileukemia immunotherapy.
    Osman Y; Takahashi M; Zheng Z; Toba K; Liu A; Furukawa T; Narita M; Aizawa Y; Koike T; Shibata A
    J Exp Clin Cancer Res; 1999 Dec; 18(4):485-92. PubMed ID: 10746975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S; Komita H; Sagawa Y; Ohno T; Toda G
    Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
    Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
    Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines.
    Wan Y; Bramson J; Pilon A; Zhu Q; Gauldie J
    Cancer Res; 2000 Jun; 60(12):3247-53. PubMed ID: 10866318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal cancer peptide-based therapeutic vaccine breaks tolerance against telomerase and eradicates established tumor.
    Dosset M; Godet Y; Vauchy C; Beziaud L; Lone YC; Sedlik C; Liard C; Levionnois E; Clerc B; Sandoval F; Daguindau E; Wain-Hobson S; Tartour E; Langlade-Demoyen P; Borg C; Adotévi O
    Clin Cancer Res; 2012 Nov; 18(22):6284-95. PubMed ID: 23032748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ targeting of dendritic cells by antigen-loaded red blood cells: A novel approach to cancer immunotherapy.
    Banz A; Cremel M; Rembert A; Godfrin Y
    Vaccine; 2010 Apr; 28(17):2965-72. PubMed ID: 20188177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells.
    Viehl CT; Tanaka Y; Chen T; Frey DM; Tran A; Fleming TP; Eberlein TJ; Goedegebuure PS
    Breast Cancer Res Treat; 2005 Jun; 91(3):271-8. PubMed ID: 15952060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.